Topic portal·6 articles
Portal:Access and cost
Coverage, price and who is left out
Introduction
Access to this class of drug is determined less by clinical eligibility than by benefit design, list price and jurisdiction. This portal covers insurance mechanics, prior authorisation and appeals, cost per milligram as a comparison metric and its limits, and the international disparities that follow from all of it.
Picture of the month
Selected article
Peptide harm reduction — Peptide harm reduction is the application of harm-reduction principles to people obtaining peptides outside regulated supply.
39 revisions since 29 November 2024. Discussion · history
Articles in this portal
Things you can do
- Date-stamp every price figure and state its currency and country.
- Avoid presenting a single insurer's policy as a general rule.
Items here are deliberately small enough to finish in one sitting. See Project:Verifiability before adding sources.